Trial Site Detail

 

Drug:
INBRX-109 + Temozolomide
Trial:
Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas
Conditions: Gastrointestinal Stromal Tumor
Trial Status:
Recruiting

 

Valkyrie Clinical Trials INC

2080 Century Park E     Suite 803
Los Angeles , CA 90067
USA

 

Principal Investigator:
 David Berz, MD
Contact:
 Francisco Capilla 213-926-1844 francisco@alacritycare.com
Activation Status of this Site:
 Active
Notes about this Site:
Valkyrie Clinical Trials INC Website:

 

 

Navigating the Map

Use the plus (+) and minus (-) controls to zoom in/out.

Click and drag the map or use the arrows to move (pan) the map.

Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.